neurology

News

Intec Pharma shares dive after Parkinson's trial failure

Intec Pharma’s Parkinson’s gradual release disease drug trial has missed its primary endpoint, causing the biotech’s share price to crash.

News

Musk's Neuralink close to clinical trials of "brain interfac...

A new brain implant technology from Elon Musk’s tech startup Neuralink could be used as a treatment for neurologic conditions and Parkinson’s disease.

News

FDA fast tracks Prevail's Parkinson's gene therapy

The FDA has fast tracked a gene therapy for a certain form of Parkinson’s Disease from US biotech Prevail Therapeutics.

News

Under threat from Novartis, Biogen hails new data from SMA d...

Under threat from a gene therapy from Novartis, Biogen is making the case for its drug Spinraza for the muscle wasting disease spinal muscular atrophy, with new data that it hopes persuades

News

Sanofi hands back neurology gene therapy rights to Voyager

Sanofi’s Genzyme unit has handed back rights to two neurology gene therapies to US biotech Voyager Therapeutics, as part of a rethink of the companies’ joint research.

News